Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 10
385
Views
4
CrossRef citations to date
0
Altmetric
Short Communications

Novel bioactive compound from the bark of Putranjiva roxburghii Wall

, , ORCID Icon & ORCID Icon
Pages 1738-1740 | Received 10 Apr 2019, Accepted 16 Jun 2019, Published online: 24 Jun 2019
 

Abstract

Putranjivah (Putranjiva roxburghii Wall, family – Putranjivaceae) is an Indian native medicinal plant used to treat many diseases such as treatment of mouth and stomach ulcers, hot swellings, smallpox, burning sensation and ophthalmopathy. The study of chemical constituents in the bark of P. roxburghii resulted in a new triterpene (6) along with five known triterpenoids (15). The chemical characterisation was based on 1H, 13C, 2D-NMR experimentation, and ESI-MS data. The anti-plasmodial activity was investigated by measuring parasite-specific lactate dehydrogenase (pLDH) based in vitro assay. The IC50 value results showed that friedlein (2.40 ± 0.70) and roxburghonol (4.10 ± 1.7 μg/ml) possess better anti-plasmodial activity than other isolated triterpenes (25) but not as potent as chloroquine (0.023 ± 0.002 μg/ml) against chloroquine-sensitive Plasmodium falciparum (3D7) strain.

GRAPHICAL ABSTRACT

Disclosure statement

We hereby confirm that authors have no conflict of interest.

Additional information

Funding

Authors thank Director, CSIR-CIMAP, Lucknow for providing necessary research facilities and infrastructure for this work. SM gratefully acknowledges the funding support received from the Department of Science and Technology (DST), New Delhi, India, for the INSPIRE Fellowship (IF-150254).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.